Results 51 to 60 of about 997,868 (317)

Pathophysiology, histopathology and therapeutic of SARS-CoV-2 [PDF]

open access: yes, 2020
The rapid transmission of SARS-CoV-2 through the world has induced the scientist to understand the histopathology of the virus and then to find an effective drug.
Al-Gheethi, Adel   +6 more
core  

Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays [PDF]

open access: yes, 2020
In response to the rapidly evolving COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) has rapidly issued 49 emergency use authorizations (EUAs) for SARS-CoV-2 in vitro diagnostic test-kits. A critical metric in the performance evaluation for
Ismagilov, Rustem F., Jue, Erik
core   +1 more source

The heart and SARS-CoV-2

open access: yesMedicina Clínica (English Edition), 2022
SARS-Cov2 is currently causing a persistent Covid-19 pandemic, which poses a risk of causing long-term cardiovascular sequels in the population. The viral mechanism of cell infection through the angiotensin 2 converter enzyme receptor and the limited antiviral innate immune response are the suspected causes for a more frequent cardiovascular damage in ...
González-Calle, David   +2 more
openaire   +3 more sources

Guillain‐Barré syndrome after SARS‐CoV‐2 infection

open access: yesJournal of General and Family Medicine, 2022
We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita   +5 more
doaj   +1 more source

Survival and disinfection of SARS-Cov-2 in environment and contaminated surface [PDF]

open access: yes, 2020
The detection of SARS-Cov-2 in the sewage and water resources has increased the awareness among the people about the possibility survival of SARS-Cov-2 in the environment and the potential to transmit into the human through food chain or water resources.
Al-Gheethi, Adel   +5 more
core  

Droplet evaporation residue indicating SARS-COV-2 survivability on surfaces

open access: yes, 2020
SARS-CoV-2 survives and remains viable on surfaces for several days under different environments as reported in recent studies. However, it is unclear how the viruses survive for such a long time and why their survivability varies across different ...
He, Zilong   +5 more
core   +1 more source

COVID-19 publications: Database coverage, citations, readers, tweets, news, Facebook walls, Reddit posts [PDF]

open access: yes, 2020
© 2020 The Authors. Published by MIT Press. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1162/qss_a_00066The COVID ...
Adie E.   +54 more
core   +2 more sources

SARS‐CoV‐2 Omicron variant: Characteristics and prevention

open access: yesMedComm, 2021
Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in
Xuemei He   +4 more
doaj   +1 more source

Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department [PDF]

open access: yes, 2020
As of March 30th, 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise.
Brown, Cortlyn   +2 more
core  

The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses [PDF]

open access: yes, 2020
We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave
Feliciello, Isidoro, Procino, Alfredo
core   +1 more source

Home - About - Disclaimer - Privacy